Viewing Study NCT06037395


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-04-05 @ 1:40 AM
Study NCT ID: NCT06037395
Status: COMPLETED
Last Update Posted: 2023-09-14
First Post: 2023-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
Sponsor: Celltrion
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CT-P41 1.2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators